Lin‐Kun An

1.6k total citations
75 papers, 1.4k citations indexed

About

Lin‐Kun An is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Lin‐Kun An has authored 75 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 30 papers in Organic Chemistry and 21 papers in Toxicology. Recurrent topics in Lin‐Kun An's work include Cancer therapeutics and mechanisms (32 papers), Bioactive Compounds and Antitumor Agents (21 papers) and Synthesis and Biological Evaluation (10 papers). Lin‐Kun An is often cited by papers focused on Cancer therapeutics and mechanisms (32 papers), Bioactive Compounds and Antitumor Agents (21 papers) and Synthesis and Biological Evaluation (10 papers). Lin‐Kun An collaborates with scholars based in China, United States and Hong Kong. Lin‐Kun An's co-authors include Zhi‐Shu Huang, Lian‐Quan Gu, Shi‐Liang Huang, Yu Qian, Jia‐Heng Tan, Ding Li, Tian‐Miao Ou, Xianzhang Bu, Huan Yan and Hai‐Yang Liu and has published in prestigious journals such as PLoS ONE, Biochemistry and Journal of Agricultural and Food Chemistry.

In The Last Decade

Lin‐Kun An

71 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin‐Kun An China 22 792 521 281 193 176 75 1.4k
Elvira E. Shults Russia 19 859 1.1× 873 1.7× 365 1.3× 122 0.6× 235 1.3× 290 1.8k
Ming‐Jaw Don Taiwan 24 688 0.9× 398 0.8× 258 0.9× 170 0.9× 262 1.5× 44 1.4k
Amit Choudhari India 14 558 0.7× 345 0.7× 165 0.6× 78 0.4× 206 1.2× 25 1.4k
Hui-Kang Wang United States 18 823 1.0× 471 0.9× 186 0.7× 121 0.6× 207 1.2× 21 1.5k
Yulin Ren United States 25 1.0k 1.3× 211 0.4× 238 0.8× 142 0.7× 354 2.0× 73 1.7k
Lo‐Ti Tsao Taiwan 26 769 1.0× 823 1.6× 343 1.2× 204 1.1× 306 1.7× 48 1.8k
Kyoko Nakagawa‐Goto United States 27 1.1k 1.3× 949 1.8× 457 1.6× 148 0.8× 223 1.3× 141 2.2k
Barbora Orlikova Luxembourg 18 444 0.6× 304 0.6× 244 0.9× 76 0.4× 99 0.6× 23 926
K. Suresh Babu India 23 577 0.7× 505 1.0× 271 1.0× 95 0.5× 380 2.2× 92 1.5k
Ghulam Abbas Miana Pakistan 18 488 0.6× 352 0.7× 175 0.6× 163 0.8× 291 1.7× 70 1.1k

Countries citing papers authored by Lin‐Kun An

Since Specialization
Citations

This map shows the geographic impact of Lin‐Kun An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin‐Kun An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin‐Kun An more than expected).

Fields of papers citing papers by Lin‐Kun An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin‐Kun An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin‐Kun An. The network helps show where Lin‐Kun An may publish in the future.

Co-authorship network of co-authors of Lin‐Kun An

This figure shows the co-authorship network connecting the top 25 collaborators of Lin‐Kun An. A scholar is included among the top collaborators of Lin‐Kun An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin‐Kun An. Lin‐Kun An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xia, Wei, Guoqiang Zhang, Lin Ye, et al.. (2025). Sterpiperazines A and B, steroid-indole alkaloids with Tdp1 inhibitory and chemotherapy sensitizing activities from marine fungus Aspergillus sp. EGF 15-0-3. Chinese Chemical Letters. 37(2). 111048–111048. 1 indexed citations
2.
Liu, Wenya, et al.. (2025). Design and synthesis of phenanthridinone and phenanthridine derivatives and their radiosensitizing activity. Bioorganic & Medicinal Chemistry. 123. 118161–118161.
3.
Hu, Jinshan, Leyi Chen, Ni Cheng, et al.. (2023). New Indole Diketopiperazine Alkaloids from Soft Coral‐Associated Epiphytic Fungus Aspergillus versicolor CGF 9‐1‐2. Chemistry & Biodiversity. 20(6). e202300301–e202300301. 7 indexed citations
4.
Qian, Jiasheng, et al.. (2023). General Synthesis of N-CF3 Heteroaryl Amides via Successive Fluorination and Acylation of Sterically Hindered Isothiocyanates. The Journal of Organic Chemistry. 88(21). 15237–15248. 5 indexed citations
6.
Yang, Hao, Min Wu, Wenjie Wang, et al.. (2022). Synthesis of 11-aminoalkoxy substituted benzophenanthridine derivatives as tyrosyl-DNA phosphodiesterase 1 inhibitors and their anticancer activity. Bioorganic Chemistry. 123. 105789–105789. 5 indexed citations
7.
Qin, Xu‐Jie, Lanjun Zhang, Yu Zhang, et al.. (2020). Polyphyllosides A–F, six new spirostanol saponins from the stems and leaves of Paris polyphylla var. chinensis. Bioorganic Chemistry. 99. 103788–103788. 28 indexed citations
8.
Yan, Huacheng, Hui Yang, Luxia Wang, et al.. (2019). ZTW-41, a Potent Indolizinoquinoline-5,12-Dione Derivative Against Drug-Resistant Staphylococci and Enterococci Bacteria. Microbial Drug Resistance. 26(2). 100–109.
9.
Yan, Huan, Yu Qian, Wei Ni, et al.. (2019). Spirostanol and sesquiterpenoid glycosides from the rhizomes of Trillium tschonoskii. Steroids. 155. 108569–108569. 5 indexed citations
10.
Qian, Yu, Yu Chen, Hui Yang, et al.. (2019). The antitumor activity of CYB-L10, a human topoisomerase IB catalytic inhibitor. Journal of Enzyme Inhibition and Medicinal Chemistry. 34(1). 818–822. 6 indexed citations
11.
Qin, Xu‐Jie, Yu Qian, Hui Liu, et al.. (2018). Eucalypglobulusals A–J, Formyl-Phloroglucinol–Terpene Meroterpenoids from Eucalyptus globulus Fruits. Journal of Natural Products. 81(12). 2638–2646. 32 indexed citations
12.
Shu, Bing, Ping Zeng, Penghui Li, et al.. (2018). Syntheses and evaluation of new Quinoline derivatives for inhibition of hnRNP K in regulating oncogene c-myc transcription. Bioorganic Chemistry. 85. 1–17. 21 indexed citations
13.
Qian, Yu, Hui Yang, Monica Abdelmalak, et al.. (2018). Synthesis and structure-activity relationship of furoquinolinediones as inhibitors of Tyrosyl-DNA phosphodiesterase 2 (TDP2). European Journal of Medicinal Chemistry. 151. 777–796. 18 indexed citations
14.
Qin, Xu‐Jie, Hui Liu, Yu Qian, et al.. (2017). Acylphloroglucinol derivatives from the twigs and leaves of Callistemon salignus. Tetrahedron. 73(14). 1803–1811. 34 indexed citations
15.
Qiu, Jun, Mingxue Wang, Yan Zhang, et al.. (2015). Biological Function and Medicinal Research Significance of G-Quadruplex Interactive Proteins. Current Topics in Medicinal Chemistry. 15(19). 1971–1987. 13 indexed citations
16.
Wu, Haiqiang, Fang Zhang, Neil R. Williamson, et al.. (2014). Effects of Secondary Metabolite Extract from Phomopsis occulta on β-Amyloid Aggregation. PLoS ONE. 9(10). e109438–e109438. 10 indexed citations
17.
Wang, Luxia, Hongbin Zhang, Jianwen Chen, et al.. (2011). Synthesis, antimicrobial activity and possible mechanism of action of 9-bromo-substituted indolizinoquinoline-5,12-dione derivatives. European Journal of Medicinal Chemistry. 46(9). 4625–4633. 12 indexed citations
18.
Gu, Lian‐Quan, et al.. (2010). Synthesis and antiproliferative activity of indolizinophthalazine-5,12-dione derivatives, DNA topoisomerase IB inhibitors. European Journal of Medicinal Chemistry. 45(9). 3938–3942. 16 indexed citations
19.
An, Lin‐Kun, et al.. (2007). The Reaction of Tanshinones with Diamines.. ChemInform. 38(3). 2 indexed citations
20.
An, Lin‐Kun, et al.. (2006). The reaction of tanshinones with diamines. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 45(9). 2105–2111. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026